ABL Biotechnologies Financials

BSE: 526955

₹0.81

₹0.02 (3.05%)

As on 11-Jul-2016IST

Market cap

₹1 Cr

Revenue (TTM)

₹-- Cr

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Operating Revenue	--	--	0.04	2.22	8.15	16.86
Total Income	--	0.01	0.05	2.23	8.16	17.01
Total Expenditure	0.03	0.12	0.57	22.23	7.77	13.68
EBITDA	-0.03	-0.12	-0.53	-20.00	0.38	3.18
Depreciation	0.11	0.07	0.07	0.12	0.23	0.22
EBIT	-0.13	-0.18	-0.60	-20.12	0.15	2.96
Interest	--	0.00	0.00	0.52	1.12	1.16
Other Income	--	0.01	0.00	0.00	0.01	0.14
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.13	-0.18	-0.60	-20.64	-0.95	1.95
Provision for Tax	--	--	--	--	0.01	0.19
Profit after Tax	-0.13	-0.18	-0.60	-20.64	-0.97	1.75

Liabilities (₹ Cr)	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Shareholder's Funds	17.90	18.56	18.74	19.33	40.21	12.62
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	12.25	12.79	12.65	16.66	16.59	14.15
Current Liabilities	13.59	13.75	13.84	9.60	8.88	7.84
Total Liabilities	43.74	45.10	45.23	45.60	65.69	34.61

Assets (₹ Cr)	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Non-Current Assets	35.95	36.11	36.16	36.40	16.35	14.93
Current Assets	7.78	8.66	8.69	8.77	48.38	19.22
Total Assets	43.74	45.10	45.23	45.60	65.69	34.61
Total Debt*	--	17.10	16.97	16.66	16.59	14.15
Net Current Assets	-5.80	-5.09	-5.15	-0.83	39.50	11.38
Contingent Liabilities	--	4.52	4.52	4.52	4.52	4.52

Cashflow (₹ Cr)	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Cash From Operating Activities	--	-0.11	-0.47	-9.56	0.78	-1.65
Cash Flow from Investing Activities	--	-0.02	0.17	-19.88	-0.89	-1.90
Cash from Financing Activities	--	0.14	0.30	-0.45	29.97	1.21
Net Cash Inflow / Outflow	--	0.00	0.00	-29.89	29.85	-2.33

Financials Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Adjusted EPS (₹)	-0.16	-0.22	-0.73	-25.17	-1.18	4.28
Cash EPS (₹)	--	-0.14	-0.64	-25.03	-0.90	4.81
Adjusted Book Value (₹)	--	17.61	17.77	18.44	43.26	20.44
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.14	-0.57	-11.66	0.95	-4.01
Free Cash Flow per Share (₹)	--	-0.21	-0.64	-47.28	-1.21	-8.27

Profitability Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
ROCE (%)	--	-0.56	-1.89	-47.98	0.45	15.11
ROE (%)	--	-1.24	-4.03	-81.59	-4.41	23.13
ROA (%)	-0.60	-0.40	-1.32	-37.09	-1.93	5.66
EBIT Margin (%)	--	--	-1,432.51	-904.53	1.89	17.56
Net Margin (%)	--	-2,757.31	-1,304.14	-926.38	-11.83	10.32
Cash Profit Margin (%)	--	--	-1,258.51	-671.94	-7.21	9.84

Growth Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Revenue Growth (%)	--	-100.00	-98.11	-72.70	-51.67	81.89
EBIT Growth (%)	12.99	69.40	97.01	-13,162.83	-94.80	96.59
Net Profit Growth (%)	13.16	70.07	97.10	-2,036.64	-155.05	-18.36
EPS Growth (%)	13.11	70.06	97.10	-2,036.64	-127.52	-18.36
Book Value Growth (%)	--	-0.89	-3.63	-57.37	323.31	23.35

Valuation Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Price / Earnings	--	--	--	--	--	16.00
Price / Book Value	0.05	0.28	0.50	1.07	0.28	3.35
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-677.96	-191.02	-45.59	-1.64	-9.13	12.65
Close Price (₹)	--	4.92	8.84	19.80	11.95	68.50
High Price (₹)	--	13.25	25.90	32.95	105.15	222.00
Low Price (₹)	--	4.77	8.00	11.50	9.10	55.70
Market Cap (₹ Cr)	0.66	--	7.25	16.24	9.80	28.08

Solvency Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Debt to Equity	0.68	1.18	1.16	1.10	0.47	1.69
Short term debt to equity ratio	0.24	0.23	0.23	--	--	--
Current Ratio	0.57	0.63	0.63	0.91	5.45	2.45
Quick Ratio	0.57	0.63	0.63	0.91	5.11	2.07
Interest Coverage	--	-114.15	-818.17	-38.58	0.15	2.69

Operating Efficiency Ratios	TTM	Mar-12	Mar-11	Mar-10	Mar-09	Mar-08	Mar-07	Mar-06	Mar-05	Mar-04	Mar-03
Debtors to sales (%)	--	--	752.28	12.28	87.87	44.78
Asset Turnover	--	--	0.00	0.05	0.20	0.65
Receivable days	--	--	2,559.66	444.28	263.44	96.68
Inventory Days	--	--	--	183.27	106.80	49.55
Payable days	--	--	--	925.24	799.90	223.17
Cash Conversion Cycle	--	--	2,559.66	-297.69	-429.66	-76.94

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.